EMEA draws up code of conduct for post-authorisation studies
This article was originally published in SRA
Executive Summary
The European Medicines Agency has drawn up a code of conduct to help guarantee high standards, scientific independence and transparency in postauthorisation studies conducted under the EU’s pharmacoepidemiology and pharmacovigilance project (ENCePP).